Search

3 result(s) for 'author#"Edward L Tobinick"' within BMC

1. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

   Substantial basic science and clinical evidence suggests that excess tumor necrosis factor-alpha (TNF-alpha) is centrally involved in the pathogenesis of Alzheimer's disease. In addition to its pro-inflammator...

   Authors: Edward L Tobinick and Hyman Gross

   Citation: Journal of Neuroinflammation 2008 5:2

   Content type: Case report

   Published on: 9 January 2008

   • View Full Text
   • View PDF

2. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease

   Recent clinical studies point to rapid and sustained clinical, cognitive, and behavioral improvement in both Alzheimer's disease and primary progressive aphasia following weekly perispinal administration of et...

   Authors: Edward L Tobinick and Hyman Gross

   Citation: BMC Neurology 2008 8:27

   Content type: Research article

   Published on: 21 July 2008

   • View Full Text
   • View PDF

3. Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging

   The cytokines interleukin-1 and tumor necrosis factor (TNF), and the cytokine blocker interleukin-1 receptor antagonist, all have been demonstrated to enter the cerebrospinal fluid (CSF) following peripheral a...

   Authors: Edward L Tobinick, Kai Chen and Xiaoyuan Chen

   Citation: BMC Research Notes 2009 2:28

   Content type: Short Report

   Published on: 27 February 2009

   • View Full Text
   • View PDF